Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)
Andreas Pinter, Matthias Augustin, Rotraut Mößner, Ulrike Hüffmeier et al.
Citations
7 citations
Journal
JAAD International
Topics
Dermatology and Skin Diseases
Field-Weighted Citation Impact (FWCI)
3.74
article
Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)
Andreas Pinter, Matthias Augustin, Rotraut Mößner, Ulrike Hüffmeier, Sascha Gerdes, Petra Staubach, Nina Magnolo, Dagmar Wilsmann‐Theis, Robert Németh, Kerstin Wolk, Ansgar Weyergraf, Cornelia Paul, Robert Sabat, Jennifer Schmitz, Selina Patt
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
JAAD InternationalVol. 18
Institutions
Goethe University Frankfurt (DE), University of Bonn (DE), Universität Hamburg (DE), Johannes Gutenberg University Mainz (DE), University Hospital Bonn (DE), Universitätsklinikum Erlangen (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), Zimmer Biomet (Germany) (DE), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Schleswig-Holstein (DE), Universitätsmedizin Göttingen (DE), University Hospital Frankfurt (DE), Charité - Universitätsmedizin Berlin (DE), B. Braun (Netherlands) (NL), University of Lübeck (DE)
Funders
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Biogen, Celgene, Hexal AG, CSL Behring, Regeneron Pharmaceuticals, Dermira, Heising-Simons Foundation, BioCryst, Mylan, Incyte, Celltrion, Argenx, IC Design Education Center, Galderma, Medac, LEO Pharma, Novartis Pharma, Principia Biopharma, Janssen Pharmaceuticals, UCB Pharma, Cilag